Weekly Newsletter   Challenge account   Weekly Newsletter   


Posts Tagged With 'potassium levels'

Relypsa’s Drug Treatment Success Threatened By Looming New Player Entranceent as Big Pharma

Biopharmaceutical company Relypsa Inc. (NASDAQ: RLYP) continues to enjoy being the sole provider of a drug used to treat hyperkalemia. Its stock is up and analysts are bullish that it has more room to run. However, there are some catalysts that could move the stock downward. Because of some issues that could affect shareholder value, Continue reading →